DAY ONE BIOPHARMACEUTI

Day One Announces Pricing of Upsized Public Offering of Common Stock

14 Jun 2022 20:00:00 By Nasdaq GlobeNewswire

Day One Announces Proposed Public Offering of Common Stock

14 Jun 2022 07:30:00 By Nasdaq GlobeNewswire

Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma

12 Jun 2022 17:00:00 By Nasdaq GlobeNewswire

Day One Announces First Patients Dosed in Phase 1b/2 Combination Study with Tovorafenib (DAY101) and Pimasertib in RAF-altered Solid Tumors

23 May 2022 08:30:00 By Nasdaq GlobeNewswire

Day One Reports First Quarter 2022 Financial Results and Provides Business Update

12 May 2022 16:30:00 By Nasdaq GlobeNewswire

Day One to Present at the 21st Annual Needham Virtual Healthcare Conference

06 Apr 2022 08:30:00 By Nasdaq GlobeNewswire

Day One Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Progress

07 Mar 2022 07:30:00 By Nasdaq GlobeNewswire

Day One to Participate in the Cowen 42nd Annual Health Care Conference

28 Feb 2022 16:05:02 By Nasdaq GlobeNewswire

Day One to Present at the 40th Annual J.P. Morgan Healthcare Conference

05 Jan 2022 08:00:02 By Nasdaq GlobeNewswire

Day One Announces First Patient Dosed in Phase 2 Monotherapy Study in RAF-altered Solid Tumors

22 Nov 2021 07:00:00 By Nasdaq GlobeNewswire

Day One to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

18 Nov 2021 08:00:02 By Nasdaq GlobeNewswire

Day One Reports Third Quarter 2021 Financial Results and Corporate Progress

08 Nov 2021 16:50:00 By Nasdaq GlobeNewswire

Day One Announces Presentation at 2021 Connective Tissue Oncology Society (CTOS) Virtual Annual Meeting

03 Nov 2021 08:00:02 By Nasdaq GlobeNewswire

Day One Appoints Jaa Roberson as Chief People Officer

13 Sep 2021 07:00:00 By Nasdaq GlobeNewswire

Day One Appoints Scott Garland to Board of Directors

17 Aug 2021 07:00:01 By Nasdaq GlobeNewswire

Day One Reports Second Quarter 2021 Financial Results and Corporate Progress

10 Aug 2021 16:05:02 By Nasdaq GlobeNewswire

Day One Biopharmaceuticals to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference

04 Aug 2021 08:00:02 By Nasdaq GlobeNewswire

Day One Receives FDA Rare Pediatric Disease Designation for DAY101 for the Treatment of Pediatric Low-Grade Glioma

27 Jul 2021 07:00:01 By Nasdaq GlobeNewswire